Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRK

Merck

$63.33

-0.06 (-0.09%)

, GSK

GlaxoSmithKline

$40.80

-0.21 (-0.51%)

15:30
10/16/17
10/16
15:30
10/16/17
15:30
Conference/Events
European Society of Gene & Cell Therapy will hold a conference »

25th Anniversary Congress…

MRK

Merck

$63.33

-0.06 (-0.09%)

GSK

GlaxoSmithKline

$40.80

-0.21 (-0.51%)

TECH

Bio-Techne

$121.65

-2.28 (-1.84%)

PLL

Pall Corp.

ICEL

Cellular Dynamics

ABEO

Abeona Therapeutics

$16.10

-1.45 (-8.26%)

KITE

Acquired by GILD 9/17

PFE

Pfizer

$35.96

-0.38 (-1.05%)

BMRN

BioMarin

$95.12

-0.01 (-0.01%)

SHPG

Shire

$154.07

1.79 (1.18%)

TIG

TiGenix

$24.54

-0.166 (-0.67%)

BIIB

Biogen

$337.64

4.33 (1.30%)

QURE

uniQure

$10.71

-0.38 (-3.43%)

SGMO

Sangamo

$14.95

-0.95 (-5.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 18

    Oct

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

  • 30

    Nov

  • 02

    Feb

  • 28

    Feb

Wednesday
GILD

Gilead

$83.04

1.06 (1.29%)

07:12
10/11/17
10/11
07:12
10/11/17
07:12
Hot Stocks
Gilead treatment of pediatric ulcerative colitis granted FDA orphan status »

Gilead's filgotinib…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Feb

GILD

Gilead

$83.04

1.06 (1.29%)

04:52
10/11/17
10/11
04:52
10/11/17
04:52
Initiation
Gilead initiated at Barclays »

Gilead reinstated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Feb

Over a week ago
GILD

Gilead

$81.98

-0.16 (-0.19%)

, BBRY

BlackBerry

$11.27

0.2 (1.81%)

07:35
10/10/17
10/10
07:35
10/10/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

GILD

Gilead

$81.98

-0.16 (-0.19%)

BBRY

BlackBerry

$11.27

0.2 (1.81%)

SBUX

Starbucks

$55.02

-0.15 (-0.27%)

MBI

MBIA

$7.68

0.03 (0.39%)

SEAS

SeaWorld

$13.69

0.4 (3.01%)

ETE

Energy Transfer Equity

$17.90

-0.02 (-0.11%)

ARNC

Arconic

$27.39

0.29 (1.07%)

XXII

22nd Century

$2.99

-0.42 (-12.32%)

ON

ON Semiconductor

$19.31

0.08 (0.42%)

CAKE

Cheesecake Factory

$41.86

0.53 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 25

    Jan

  • 12

    Feb

GILD

Gilead

$82.14

-1.37 (-1.64%)

10:20
10/09/17
10/09
10:20
10/09/17
10:20
Options
Gilead Sciences with a sizable ratio spread »

Gilead Sciences with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Feb

ABBV

AbbVie

$90.49

0.31 (0.34%)

, INCY

Incyte

$114.70

1.13 (0.99%)

09:05
10/09/17
10/09
09:05
10/09/17
09:05
Recommendations
AbbVie, Incyte, Eli Lilly, Gilead analyst commentary at Leerink »

Leerink not worried about…

ABBV

AbbVie

$90.49

0.31 (0.34%)

INCY

Incyte

$114.70

1.13 (0.99%)

LLY

Eli Lilly

$87.08

-0.57 (-0.65%)

GILD

Gilead

$82.14

-1.37 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 17

    Oct

  • 18

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 08

    Nov

  • 12

    Feb

JUNO

Juno Therapeutics

$43.61

-1.11 (-2.48%)

, GILD

Gilead

$82.14

-1.37 (-1.64%)

07:56
10/09/17
10/09
07:56
10/09/17
07:56
Recommendations
Juno Therapeutics, Gilead, Novartis analyst commentary at Maxim »

Juno price target raised…

JUNO

Juno Therapeutics

$43.61

-1.11 (-2.48%)

GILD

Gilead

$82.14

-1.37 (-1.64%)

NVS

Novartis

$85.77

0.13 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 08

    Nov

  • 12

    Feb

  • 17

    May

GILD

Gilead

$82.42

-0.77 (-0.93%)

, TUSK

Mammoth Energy

$15.58

-0.78 (-4.77%)

10:36
10/05/17
10/05
10:36
10/05/17
10:36
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

GILD

Gilead

$82.42

-0.77 (-0.93%)

TUSK

Mammoth Energy

$15.58

-0.78 (-4.77%)

HSKA

Heska

$91.38

1.94 (2.17%)

ANGI

Angie's List

$11.81

-0.76 (-6.05%)

CSGP

CoStar Group

$271.79

0.16 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 11

    Oct

  • 12

    Oct

  • 09

    Nov

  • 15

    Nov

  • 12

    Feb

  • 15

    May

  • 16

    May

GILD

Gilead

$82.42

-0.7708 (-0.93%)

16:08
10/04/17
10/04
16:08
10/04/17
16:08
Initiation
Gilead initiated at Oppenheimer »

Gilead initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

  • 12

    Feb

JNCE

Jounce Therapeutics

$16.81

-0.16 (-0.94%)

, TOCA

Tocagen

$12.23

-0.39 (-3.09%)

08:30
10/04/17
10/04
08:30
10/04/17
08:30
Options
Two new option listings and two option delistings on October 4th »

New option listings for…

JNCE

Jounce Therapeutics

$16.81

-0.16 (-0.94%)

TOCA

Tocagen

$12.23

-0.39 (-3.09%)

ALR

Alere

KITE

Acquired by GILD 9/17

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.